Australia's most trusted
source of pharma news
Posted 17 May 2022 PM
Two homegrown Covid vaccines are going head-to-head in a new study investigating their effectiveness when given as a fourth dose.
The randomised, placebo-controlled study marks the first time a side-by-side comparison will be undertaken of protein and mRNA based COVID-19 vaccine platforms.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.